Double maintains 1 strategies that include APGE - Apogee Therapeutics, Inc.
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 129.1% in Apogee Therapeutics Inc. (APGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Apogee Therapeutics is a clinical-stage biotechnology compa
Yahoo
The consensus price target hints at a 132.7% upside potential for Apogee Therapeutics Inc. (APGE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Finnhub
SAN FRANCISCO, BOSTON - Apogee Therapeutics, Inc., , a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory...
Yahoo
Apogee Therapeutics, Inc. (NASDAQ:APGE) on Monday revealed interim data from its Phase 1b trial of APG808, a novel half-life extended IL-4Rα antibody, in patients with mild-to-moderate asthma. The Phase 1b double-blind, placebo-controlled, multiple-dose trial evaluated the safety and tolerability of APG808 in 22 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide concentration (FeNO), TARC, and pSTAT6. Participants were randomized 3:1, receiving
SeekingAlpha
Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma treatment. Click for my APGE stock update.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYRE | 52.70% | $1.04B | -45.13% | 0.00% |
CRNX | 51.71% | $2.98B | -29.91% | 0.00% |
ATXS | 50.78% | $322.80M | -37.49% | 0.00% |
OCUL | 50.10% | $1.39B | +51.83% | 0.00% |
KRYS | 49.74% | $3.96B | -22.90% | 0.00% |
DYN | 48.60% | $1.64B | -56.43% | 0.00% |
CLDX | 48.30% | $1.41B | -38.68% | 0.00% |
DNLI | 48.24% | $2.11B | -29.81% | 0.00% |
RCUS | 48.18% | $978.38M | -45.55% | 0.00% |
IDYA | 48.02% | $1.94B | -41.80% | 0.00% |
ELVN | 47.76% | $1.08B | +0.97% | 0.00% |
BEAM | 47.28% | $1.72B | -31.40% | 0.00% |
ACLX | 46.75% | $3.64B | +21.30% | 0.00% |
IMNM | 46.51% | $800.51M | -38.34% | 0.00% |
XNCR | 44.86% | $654.06M | -55.34% | 0.00% |
RVMD | 44.69% | $7.56B | +5.10% | 0.00% |
NTLA | 43.88% | $860.77M | -66.96% | 0.00% |
XENE | 43.65% | $2.51B | -12.05% | 0.00% |
NRIX | 43.59% | $909.49M | -21.41% | 0.00% |
VRDN | 43.45% | $1.30B | +27.65% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTM | 0.09% | $320.83M | 0.07% |
YEAR | -0.11% | $1.44B | 0.25% |
MLN | -0.15% | $526.67M | 0.24% |
IBTK | 0.18% | $434.62M | 0.07% |
IBTL | -0.23% | $375.79M | 0.07% |
JMST | -0.33% | $3.96B | 0.18% |
SCHR | 0.34% | $10.71B | 0.03% |
LMBS | 0.43% | $5.06B | 0.64% |
SPTI | 0.43% | $8.66B | 0.03% |
IBMN | -0.43% | $449.05M | 0.18% |
DFNM | 0.44% | $1.56B | 0.17% |
STIP | -0.46% | $12.60B | 0.03% |
TYA | 0.52% | $148.61M | 0.15% |
BSV | 0.52% | $38.05B | 0.03% |
SHY | 0.56% | $23.91B | 0.15% |
AGGH | 0.58% | $317.99M | 0.29% |
AGZ | 0.60% | $610.44M | 0.2% |
VGIT | -0.66% | $31.59B | 0.04% |
FXE | -0.72% | $566.52M | 0.4% |
BILZ | 0.73% | $840.32M | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 63.54% | $4.76B | 0.35% |
IBB | 56.71% | $5.43B | 0.45% |
PBE | 55.41% | $226.09M | 0.58% |
GNOM | 54.97% | $44.57M | 0.5% |
ARKG | 51.30% | $974.51M | 0.75% |
IWC | 49.63% | $810.66M | 0.6% |
BBH | 49.32% | $341.71M | 0.35% |
IWO | 49.12% | $11.29B | 0.24% |
FBT | 48.95% | $1.03B | 0.54% |
PINK | 48.01% | $132.70M | 0.5% |
VTWO | 47.59% | $12.36B | 0.07% |
IWM | 47.43% | $64.27B | 0.19% |
PTH | 46.85% | $103.32M | 0.6% |
KJUL | 46.67% | $119.49M | 0.79% |
SCHA | 46.55% | $17.04B | 0.04% |
NUSC | 45.95% | $1.14B | 0.31% |
ISCG | 45.72% | $667.95M | 0.06% |
KJAN | 45.49% | $289.07M | 0.79% |
XPH | 45.20% | $153.44M | 0.35% |
VBK | 45.17% | $18.61B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -36.18% | $291.96M | 1.43% |
VIXY | -35.03% | $181.73M | 0.85% |
TAIL | -33.76% | $104.89M | 0.59% |
IVOL | -15.84% | $358.40M | 1.02% |
FXY | -15.56% | $862.15M | 0.4% |
CTA | -10.92% | $1.09B | 0.76% |
ULST | -9.22% | $667.54M | 0.2% |
SPTS | -8.70% | $5.78B | 0.03% |
STOT | -8.66% | $238.61M | 0.45% |
XONE | -8.40% | $639.82M | 0.03% |
SHYM | -8.04% | $324.56M | 0.35% |
KCCA | -6.91% | $98.43M | 0.87% |
UTWO | -6.68% | $375.31M | 0.15% |
STPZ | -6.42% | $452.13M | 0.2% |
TPMN | -5.74% | $30.75M | 0.65% |
TBLL | -5.46% | $2.24B | 0.08% |
BSMW | -5.19% | $102.44M | 0.18% |
VGSH | -5.09% | $22.51B | 0.03% |
FTSD | -4.82% | $228.58M | 0.25% |
SCHO | -4.77% | $10.95B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
T | -0.04% | $202.84B | +59.81% | 3.95% |
EXC | -0.14% | $43.66B | +21.69% | 3.61% |
KMB | 0.29% | $43.41B | -6.20% | 3.78% |
SYPR | 0.31% | $49.41M | +8.59% | 0.00% |
CVS | 0.36% | $85.34B | +12.02% | 3.93% |
MSIF | -0.38% | $807.19M | +42.75% | 6.25% |
PPC | -0.39% | $10.94B | +49.72% | 0.00% |
AEP | -0.53% | $54.97B | +16.93% | 3.56% |
MCK | -0.68% | $91.11B | +23.43% | 0.39% |
COR | -0.89% | $57.28B | +27.10% | 0.73% |
ARLP | 1.08% | $3.34B | +10.60% | 10.79% |
GFI | 1.11% | $23.01B | +89.88% | 2.20% |
DFDV | 1.18% | $379.06M | +2,332.08% | 0.00% |
RPRX | -1.19% | $14.68B | +29.42% | 2.46% |
BPT | 1.21% | $15.09M | -71.10% | 0.00% |
UTZ | 1.39% | $1.13B | -25.74% | 1.83% |
CHD | 1.45% | $23.91B | -9.85% | 1.19% |
ZCMD | -1.57% | $29.04M | -3.36% | 0.00% |
CME | -2.04% | $97.12B | +36.71% | 3.92% |
FYBR | 2.06% | $9.03B | +44.11% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -18.21% | $4.90K | -99.92% | 0.00% |
K | -14.66% | $27.71B | +38.87% | 2.84% |
PULM | -12.65% | $28.52M | +307.26% | 0.00% |
CBOE | -12.35% | $23.65B | +34.73% | 1.12% |
STG | -12.03% | $29.38M | -15.04% | 0.00% |
VHC | -9.25% | $36.37M | +130.03% | 0.00% |
WBA | -9.15% | $9.86B | -26.75% | 4.39% |
VSTA | -8.19% | $344.07M | +37.94% | 0.00% |
AGL | -7.79% | $890.00M | -68.84% | 0.00% |
KR | -6.06% | $43.65B | +30.13% | 1.95% |
UUU | -4.85% | $7.19M | +93.17% | 0.00% |
KO | -4.60% | $305.69B | +13.54% | 3.48% |
RILY | -4.52% | $89.36M | -85.78% | 0.00% |
AQB | -4.36% | $3.14M | -53.66% | 0.00% |
LITB | -4.25% | $23.54M | -75.48% | 0.00% |
VSA | -4.19% | $8.76M | -16.94% | 0.00% |
IMNN | -3.99% | $25.08M | +27.68% | 0.00% |
NEUE | -3.97% | $61.16M | +27.09% | 0.00% |
ED | -3.80% | $37.46B | +14.41% | 3.24% |
MO | -3.74% | $100.75B | +34.95% | 6.89% |
Current Value
$44.651 Year Return
Current Value
$44.651 Year Return